Pravin Iyer

Title: Pravin Iyer: Innovator in Pharmaceutical Compounds

Introduction

Pravin Iyer is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that have potential therapeutic applications.

Latest Patents

Pravin Iyer holds a patent for "Substituted sulfoximine compounds." This invention relates to novel heterocyclic compounds of the general formula (I), including their pharmaceutically acceptable salts, solvates, enantiomers, diastereomers, and polymorphs. The invention also encompasses processes for preparing these compounds, pharmaceutical compositions containing them, and their use as NOD-like receptor family (NLR) protein NLRP3 modulators. The compounds are particularly relevant in the treatment of diseases or conditions mediated by NLRP3, as well as those involving interleukin-1β and interleukin-18 (IL-18) activity.

Career Highlights

Pravin Iyer is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work focuses on innovative solutions that address critical health challenges through advanced research and development.

Collaborations

Pravin collaborates with talented professionals in his field, including Rajiv Sharma and Sameer Agarwal. Their combined expertise contributes to the advancement of pharmaceutical innovations.

Conclusion

Pravin Iyer's work exemplifies the impact of innovation in the pharmaceutical sector. His contributions through patented inventions are paving the way for new treatments and therapies that can significantly improve patient outcomes.